Targeted therapy in Bangkok typically costs from $3,800 / ฿129,200 to $11,000 / ฿374,000. Total expenses depend on the drug regimen, cancer type, and required molecular profiling tests. Patients save around _price_percent_discount_% compared to the US, where this procedure costs _price_compare_US_average_ on average. Pricing usually covers oncologist consultations and medication administration within specialized cancer centers.
Bookimed Expert Insight: Bangkok is Thailand's primary hub for genomic-driven oncology, hosting centers that treat over one million patients annually. The city offers a unique blend of JCI-accredited precision medicine and integrative care. Hospitals like Bumrungrad International combine AI-driven diagnostics with localized drug sourcing to optimize costs. This infrastructure allows international patients to access advanced molecular targeting at a fraction of Western prices.
| Thailand | Turkey | Austria | |
| Lutetium-177 therapy | from $12,000 / ฿408,000 | from $8,800 / ฿299,200 | from $35,000 / ฿1,190,000 |
| Actinium-225 Therapy | from $25,000 / ฿850,000 | from $22,955 / ฿780,470 | from $55,000 / ฿1,870,000 |
| Oncothermia | from $3,600 / ฿122,400 | from $450 / ฿15,300 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Targeted therapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Targeted therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Targeted therapy journey.
Day 1: Arrival
Day 2: Pre-Operation Stage
Day 3: Targeted Therapy
Day 4: Post-Operation Stage
Week 1-2: Rehabilitation
Please note that each patient"s case is individual and can vary.
The doctor is an experienced oncologist and oncohematologist with a specialization in bone marrow transplants. They have dedicated their career to advancing treatments in oncology and hematology, focusing on innovative therapies and patient care. The doctor has contributed significantly to clinical research in their field, enhancing treatment protocols and improving patient outcomes. Their work in bone marrow transplantation is particularly notable, with a track record of successful procedures and improved survival rates for patients.
Written by Anna Shchur